These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7700959)

  • 1. Tolerance to competitive NMDA antagonists, but no crosstolerance with barbiturates.
    Rabbani M; Wright EJ; Little HJ
    Pharmacol Biochem Behav; 1995 Jan; 50(1):9-15. PubMed ID: 7700959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.
    Rabbani M; Wright J; Butterworth AR; Zhou Q; Little HJ
    Br J Pharmacol; 1994 Jan; 111(1):89-96. PubMed ID: 7912157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks.
    Bischoff C; Tiedtke PI
    Eur J Pharmacol; 1992 Mar; 213(2):269-73. PubMed ID: 1355738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on ethanol withdrawal hyperexcitability of chronic treatment with a competitive N-methyl-D-aspartate receptor antagonist.
    Ripley TL; Little HJ
    J Pharmacol Exp Ther; 1995 Jan; 272(1):112-8. PubMed ID: 7815323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor antagonists inhibit ethanol-produced locomotor stimulation in NMRI mice.
    Liljequist S
    Alcohol; 1991; 8(4):309-12. PubMed ID: 1678606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice.
    Fredriksson A; Gentsch C; Archer T
    J Neural Transm Gen Sect; 1994; 97(3):197-209. PubMed ID: 7873129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus.
    Harvey BH; Jonker LP; Brand L; Heenop M; Stein DJ
    Life Sci; 2002 May; 71(1):43-54. PubMed ID: 12020747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CGP39551 administration on the kindling of ethanol-withdrawal seizures.
    Ripley TL; Dunworth SJ; Stephens DN
    Psychopharmacology (Berl); 2002 Sep; 163(2):157-65. PubMed ID: 12202962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.
    Tzschentke TM; Schmidt WJ
    Neurosci Lett; 1995 Jun; 193(1):37-40. PubMed ID: 7566661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR; Liljequist S
    J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol withdrawal hyperexcitability in vitro is selectively decreased by a competitive NMDA receptor antagonist.
    Ripley TL; Little HJ
    Brain Res; 1995 Nov; 699(1):1-11. PubMed ID: 8616595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1994 Jan; 47(1):127-31. PubMed ID: 7906888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting ibogaine protection against NMDA-induced convulsions in mice.
    Leal MB; de Souza DO; Elisabetsky E
    Neurochem Res; 2000 Aug; 25(8):1083-7. PubMed ID: 11055745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors.
    Kretschmer BD
    J Neurochem; 1999 Aug; 73(2):839-48. PubMed ID: 10428083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
    Bubser M; Keseberg U; Notz PK; Schmidt WJ
    Eur J Pharmacol; 1992 Dec; 229(1):75-82. PubMed ID: 1361915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists.
    Meyer PJ; Phillips TJ
    Psychopharmacology (Berl); 2007 Nov; 195(1):103-15. PubMed ID: 17653696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.
    Kosowski AR; Cebers G; Cebere A; Swanhagen AC; Liljequist S
    Psychopharmacology (Berl); 2004 Aug; 175(1):114-23. PubMed ID: 15088078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.